Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


12.06.2017

1 Am J Surg
10 Ann Surg
3 BMC Cancer
5 Br J Cancer
1 Cancer
3 Cancer Lett
4 Clin Cancer Res
1 Dis Colon Rectum
1 Eur J Cancer
2 Eur J Surg Oncol
5 Gastroenterology
2 Gastrointest Endosc
1 Int J Cancer
8 Int J Colorectal Dis
5 Lancet Oncol
4 Oncol Rep
1 PLoS Med
1 PLoS One
2 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. ADAM MA, Turner MC, Sun Z, Kim J, et al
    The appropriateness of 30-day mortality as a quality metric in colorectal cancer surgery.
    Am J Surg. 2017 Jun 3. pii: S0002-9610(16)31058.
    PubMed     Text format     Abstract available


    Ann Surg

  2. SILVA-VELAZCO J, Dietz DW, Stocchi L, Costedio M, et al
    Considering Value in Rectal Cancer Surgery: An Analysis of Costs and Outcomes Based on the Open, Laparoscopic, and Robotic Approach for Proctectomy.
    Ann Surg. 2017;265:960-968.
    PubMed     Text format     Abstract available

  3. CHAN JC, Chan DL, Diakos CI, Engel A, et al
    The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Ann Surg. 2017;265:539-546.
    PubMed     Text format     Abstract available

  4. DANIELSEN AK, Park J, Jansen JE, Bock D, et al
    Early Closure of a Temporary Ileostomy in Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial.
    Ann Surg. 2017;265:284-290.
    PubMed     Text format     Abstract available

  5. BETTONI F, Masotti C, Habr-Gama A, Correa BR, et al
    Intratumoral Genetic Heterogeneity in Rectal Cancer: Are Single Biopsies representative of the entirety of the tumor?
    Ann Surg. 2017;265:e4-e6.
    PubMed     Text format     Abstract available

  6. SIMILLIS C, Baird DL, Kontovounisios C, Pawa N, et al
    A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer.
    Ann Surg. 2017;265:291-299.
    PubMed     Text format     Abstract available

  7. TANAKA K, Kikuchi Y, Kawaguchi D, Murakami T, et al
    Modified ALPPS Procedures Avoiding Division of Portal Pedicles.
    Ann Surg. 2017;265:e14-e20.
    PubMed     Text format     Abstract available

  8. ANSARI N, Solomon MJ, Fisher RJ, Mackay J, et al
    Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
    Ann Surg. 2017;265:882-888.
    PubMed     Text format     Abstract available

  9. DENOST Q, Rouanet P, Faucheron JL, Panis Y, et al
    To Drain or Not to Drain Infraperitoneal Anastomosis After Rectal Excision for Cancer: The GRECCAR 5 Randomized Trial.
    Ann Surg. 2017;265:474-480.
    PubMed     Text format     Abstract available

  10. YEO HL, Abelson JS, Mao J, O'Mahoney PR, et al
    Surgeon Annual and Cumulative Volumes Predict Early Postoperative Outcomes after Rectal Cancer Resection.
    Ann Surg. 2017;265:151-157.
    PubMed     Text format     Abstract available

  11. BALENTINE CJ, Richardson PA, Mason MC, Naik AD, et al
    Postacute Care and Recovery After Cancer Surgery: Still a Long Way to Go.
    Ann Surg. 2017;265:993-999.
    PubMed     Text format     Abstract available


    BMC Cancer

  12. CREMOLINI C, Marmorino F, Loupakis F, Masi G, et al
    TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
    BMC Cancer. 2017;17:408.
    PubMed     Text format     Abstract available

  13. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
    The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study.
    BMC Cancer. 2017;17:404.
    PubMed     Text format     Abstract available

  14. WON DD, Lee JI, Lee IK, Oh ST, et al
    The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.
    BMC Cancer. 2017;17:403.
    PubMed     Text format     Abstract available


    Br J Cancer

  15. BENITEZ-MAJANO S, Fowler H, Maringe C, Di Girolamo C, et al
    Deriving stage at diagnosis from multiple population-based sources: colorectal and lung cancer in England.
    Br J Cancer. 2016 Jun 21. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available

  16. STAFF S, Aaltonen M, Huhtala H, Pylvanainen K, et al
    Endometrial cancer risk factors among Lynch syndrome women: a retrospective cohort study.
    Br J Cancer. 2016 Jun 23. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available

  17. BLINMAN P, Mileshkin L, Khaw P, Goss G, et al
    Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.
    Br J Cancer. 2016 Oct 20. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available

  18. YOKOI K, Yamashita K, Ishii S, Tanaka T, et al
    Comprehensive molecular exploration identified promoter DNA methylation of the CRBP1 gene as a determinant of radiation sensitivity in rectal cancer.
    Br J Cancer. 2017;116:1046-1056.
    PubMed     Text format     Abstract available

  19. ALVI MA, Loughrey MB, Dunne P, McQuaid S, et al
    Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.
    Br J Cancer. 2017 Jun 8. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  20. AMINI A, Jones BL, Ghosh D, Schefter TE, et al
    Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: Analysis of the National Cancer Data Base.
    Cancer. 2017;123:228-236.
    PubMed     Text format     Abstract available


    Cancer Lett

  21. DONG X, Liao W, Zhang L, Tu X, et al
    RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Cancer Lett. 2017 Jun 6. pii: S0304-3835(17)30370.
    PubMed     Text format     Abstract available

  22. NAGARAJU GP, Wu C, Merchant N, Chen Z, et al
    Epigenetic effects of inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer.
    Cancer Lett. 2017 Jun 3. pii: S0304-3835(17)30357.
    PubMed     Text format     Abstract available

  23. NAKAMURA Y, Hattori N, Iida N, Yamashita S, et al
    Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway.
    Cancer Lett. 2017 May 31. pii: S0304-3835(17)30353.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  24. SCHOLER LV, Reinert T, Orntoft MW, Kassentoft CG, et al
    Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer.
    Clin Cancer Res. 2017 Jun 9. pii: clincanres.0510.2017.
    PubMed     Text format     Abstract available

  25. PRIEUR A, Cappellini M, Habif G, Lefranc MP, et al
    Targeting the Wnt pathway and cancer stem cells with anti-progastrin humanized antibodies: a major breakthrough for K-RAS mutated colorectal cancer treatment.
    Clin Cancer Res. 2017 Jun 9. pii: clincanres.0533.2017.
    PubMed     Text format     Abstract available

  26. PEKOW J, Meckel K, Dougherty U, Huang Y, et al
    miR-193a-3p is a key tumor suppressor in ulcerative colitis-associated colon cancer and promotes carcinogenesis through up-regulation of IL17RD.
    Clin Cancer Res. 2017 Jun 9. pii: clincanres.0171.2017.
    PubMed     Text format     Abstract available

  27. GARLAN F, Laurent-Puig P, Sefrioui D, Siauve N, et al
    Early evaluation of circulating tumor DNA as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL study).
    Clin Cancer Res. 2017 Jun 2. pii: clincanres.3155.2016.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  28. MIYO M, Takemasa I, Ishihara H, Hata T, et al
    Long-term Outcomes of Single-Site Laparoscopic Colectomy With Complete Mesocolic Excision for Colon Cancer: Comparison With Conventional Multiport Laparoscopic Colectomy Using Propensity Score Matching.
    Dis Colon Rectum. 2017;60:664-673.
    PubMed     Text format     Abstract available


    Eur J Cancer

  29. THOMSEN M, Guren MG, Skovlund E, Glimelius B, et al
    Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status.
    Eur J Cancer. 2017;81:26-35.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  30. LIBERALE G, Bourgeois P, Larsimont D, Moreau M, et al
    Indocyanine green fluorescence-guided surgery after IV injection in metastatic colorectal cancer: A systematic review.
    Eur J Surg Oncol. 2017 May 8. pii: S0748-7983(17)30457.
    PubMed     Text format     Abstract available

  31. SLOOTHAAK DAM, van der Linden RLA, van de Velde CJH, Bemelman WA, et al
    Prognostic implications of occult nodal tumour cells in stage I and II colon cancer: The correlation between micrometastasis and disease recurrence.
    Eur J Surg Oncol. 2017 May 5. pii: S0748-7983(17)30454.
    PubMed     Text format     Abstract available


    Gastroenterology

  32. JANSEN AM, Crobach S, Geurts-Giele WR, van den Akker BE, et al
    Distinct Patterns of Somatic Mosaicism in the APC Gene in Neoplasms From Patients With Unexplained Adenomatous Polyposis.
    Gastroenterology. 2017;152:546-549.
    PubMed     Text format     Abstract available

  33. REX DK, Boland CR, Dominitz JA, Giardiello FM, et al
    Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35599.
    PubMed     Text format     Abstract available

  34. KIM HB, Kim M, Park YS, Park I, et al
    Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice.
    Gastroenterology. 2017;152:616-630.
    PubMed     Text format     Abstract available

  35. YOSHIKAWA T, Wu J, Otsuka M, Kishikawa T, et al
    Repression of MicroRNA Function Mediates Inflammation-associated Colon Tumorigenesis.
    Gastroenterology. 2017;152:631-643.
    PubMed     Text format     Abstract available

  36. VELAYOS F, Kathpalia P, Finlayson E
    Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary?
    Gastroenterology. 2017;152:440-450.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  37. REX DK, Boland CR, Dominitz JA, Giardiello FM, et al
    Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer.
    Gastrointest Endosc. 2017 May 20. pii: S0016-5107(17)31805.
    PubMed     Text format    

  38. VERSTOCKT B, Van Driessche A, De Man M, van der Spek P, et al
    Ten-year survival after endoscopic stenting as a bridge to surgery in obstructing colon cancer.
    Gastrointest Endosc. 2017 Jun 1. pii: S0016-5107(17)31986.
    PubMed     Text format     Abstract available


    Int J Cancer

  39. YANG Y, Wang G, He J, Ren S, et al
    Gender differences in colorectal cancer survival: A Meta-analysis.
    Int J Cancer. 2017 Jun 9. doi: 10.1002/ijc.30827.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  40. GOLDSTONE RN, Hasan SR, Drury S, Darragh TM, et al
    A trial of radiofrequency ablation for anal intraepithelial neoplasia.
    Int J Colorectal Dis. 2017;32:357-365.
    PubMed     Text format     Abstract available

  41. RIBAS Y, Aguilar F, Jovell-Fernandez E, Cayetano L, et al
    Clinical application of the LARS score: results from a pilot study.
    Int J Colorectal Dis. 2017;32:409-418.
    PubMed     Text format     Abstract available

  42. ABBAS MA, Kharabadze G, Ross EM, Abbass MA, et al
    Predictors of outcome for endoscopic colorectal stenting: a decade experience.
    Int J Colorectal Dis. 2017;32:375-382.
    PubMed     Text format     Abstract available

  43. RUNAU F, Collins A, Fenech GA, Ford E, et al
    A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.
    Int J Colorectal Dis. 2017;32:341-348.
    PubMed     Text format     Abstract available

  44. KANG DW, Kwak HD, Sung NS, Yang IS, et al
    Oncologic outcomes in rectal cancer patients with a </=1-cm distal resection margin.
    Int J Colorectal Dis. 2017;32:325-332.
    PubMed     Text format     Abstract available

  45. KELLEY SR
    Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature.
    Int J Colorectal Dis. 2017;32:295-304.
    PubMed     Text format     Abstract available

  46. GEORGIOU PA, Mohammed Ali S, Brown G, Rasheed S, et al
    Extended lymphadenectomy for locally advanced and recurrent rectal cancer.
    Int J Colorectal Dis. 2017;32:333-340.
    PubMed     Text format     Abstract available

  47. OGURA A, Akiyoshi T, Yamamoto N, Kawachi H, et al
    Does the depth of mesorectal invasion have prognostic significance in patients with ypT3 lower rectal cancer treated with preoperative chemoradiotherapy?
    Int J Colorectal Dis. 2017;32:349-356.
    PubMed     Text format     Abstract available


    Lancet Oncol

  48. MORRIS VK, Salem ME, Nimeiri H, Iqbal S, et al
    Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
    Lancet Oncol. 2017;18:446-453.
    PubMed     Text format     Abstract available

  49. GLYNNE-JONES R, Adams R, Lopes A, Meadows H, et al
    Clinical endpoints in trials of chemoradiation for patients with anal cancer.
    Lancet Oncol. 2017;18:e218-e227.
    PubMed     Text format     Abstract available

  50. GLYNNE-JONES R, Sebag-Montefiore D, Meadows HM, Cunningham D, et al
    Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial.
    Lancet Oncol. 2017;18:347-356.
    PubMed     Text format     Abstract available

  51. ERLANDSSON J, Holm T, Pettersson D, Berglund A, et al
    Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
    Lancet Oncol. 2017;18:336-346.
    PubMed     Text format     Abstract available

  52. TSENG J, Bryan DS, Poli E, Sharma M, et al
    Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer.
    Lancet Oncol. 2017;18:711-712.
    PubMed     Text format    


    Oncol Rep

  53. ZHANG X, Sukamporn P, Zhang S, Min KW, et al
    3,3'-diindolylmethane downregulates cyclin D1 through triggering endoplasmic reticulum stress in colorectal cancer cells.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5693.
    PubMed     Text format     Abstract available

  54. DE ALMEIDA CV, Zamame JA, Romagnoli GG, Rodrigues CP, et al
    Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5692.
    PubMed     Text format     Abstract available

  55. KOWALCZYK AE, Krazinski BE, Godlewski J, Kiewisz J, et al
    Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5687.
    PubMed     Text format     Abstract available

  56. ALTOBELLI E, Latella G, Morroni M, Licini C, et al
    Low HtrA1 expression in patients with longstanding ulcerative colitis and colorectal cancer.
    Oncol Rep. 2017 Jun 6. doi: 10.3892/or.2017.5700.
    PubMed     Text format     Abstract available


    PLoS Med

  57. KHANKARI NK, Shu XO, Wen W, Kraft P, et al
    Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.
    PLoS Med. 2016;13:e1002118.
    PubMed     Text format     Abstract available


    PLoS One

  58. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    PubMed     Text format     Abstract available


    World J Surg

  59. KANORIA S, Robertson FP, Mehta NN, Fusai G, et al
    Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis: A Pilot Randomised Controlled Feasibility Trial.
    World J Surg. 2017;41:1322-1330.
    PubMed     Text format     Abstract available

  60. JI WB, Hahn KY, Kwak JM, Kang DW, et al
    Mechanical Bowel Preparation Does Not Affect Clinical Severity of Anastomotic Leakage in Rectal Cancer Surgery.
    World J Surg. 2017;41:1366-1374.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: